There are 11 GLP ones approved today, about six of them are effective for weight loss. They have become standard of care for type two diabetes diagnosis. The American Medical Association voted in 2013 that obesity is a chronic disease and we need to start treating it because this is the next diabetes. But there's so a long way to go right on the obesity drugs, you're still at 30 to 40%.
Molly rides solo today as she breaks down Amazon’s new telehealth business, Amazon Clinic. (1:40) Then, Calibrate CEO Isabelle Kenyon joins Molly for another edition of the Next Unicorns! (9:30)
(0:00) Molly tees up today's topics!
(1:40) Molly breaks down Amazon clinic
(8:15) OpenPhone - Get an extra 20% off any plan for your first 6 months at https://openphone.com/twist
(9:30) Calibrate CEO & Founder Isabelle Kenyon joins Molly for the Next Unicorns to chat about calibrate and GLP-1s
(20:52) LinkedIn Marketing - Get a $100 LinkedIn ad credit at LinkedIn.com/nextunicorn
(22:30) Understanding how inflammation causes many chronic diseases + obesity epidemic
(35:51) MicroAcquire - Sell your business with no fees at https://try.microacquire.com/twist
(37:19) Calibrate’s enterprise business + inequality in healthcare
Check out Calibrate: https://www.joincalibrate.com
FOLLOW Jason: https://linktr.ee/calacanis
FOLLOW Molly: https://twitter.com/mollywood
Subscribe to our YouTube to watch all full episodes:
https://www.youtube.com/channel/UCkkhmBWfS7pILYIk0izkc3A?sub_confirmation=1